Completed
Fostering Pragmatic Comparative-Effectiveness Trials in Non-communicable Diseases (EffecTrial)
The Research Council of Norway is announcing NOK 10 million to Norwegian researchers who want to participate in transnational investigator-initiated clinical studies.
The aims of the call are to to to support randomized, interventional and pragmatic comparative-effectiveness multi-country Investigator-Initiated Clinical Studies (IICS) and to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct comparative-effectiveness multi-country IICS.
Proposals should address all the 4 following points:
- Be a pragmatic comparative effectiveness trials, designed as randomised interventional trials.
- Compare the use of currently approved healthcare interventions either to each other or to the current standard of care.
- They shall consider healthcare interventions which could include but would not be limited to: diagnostic, screening, prevention and treatment interventions. The interventions can be pharmacological as well as non-pharmacological procedures like nutrition and/or lifestyle
interventions, surgery, prognosis methods, use of medical devices, eHealth and digital interventions and other health interventions. - These interventions shall have high public relevance only in the fields of these specific diseases or conditions (that are of equal importance): Cardiovascular diseases, Metabolic disorders, Nutrition and lifestyle-related diseases and Non-communicable respiratory diseases